[
    [
        {
            "time": "2023-01-01",
            "original_text": "Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings",
            "features": {
                "keywords": [
                    "Demand",
                    "COVID-19 Tests",
                    "Drive",
                    "Abbott",
                    "Q4 Earnings"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip™ Device",
            "features": {
                "keywords": [
                    "Abbott",
                    "Expanded Medicare Reimbursement",
                    "MitraClip™ Device"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip™ Device",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic",
            "features": {
                "keywords": [
                    "Zacks Analyst Blog",
                    "Quest Diagnostics",
                    "Abbott",
                    "Becton",
                    "Dickinson and Co",
                    "Quidel",
                    "Hologic"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]